92948-25-9

Basic information

• Product Name: 1-Pentanol, 5-chloro-, 4-methylbenzenesulfonate
• CAS NO: 92948-25-9
• Molecular Formula: C12H17ClO3S
• Molecular Weight: 276.784
• Mol File: 92948-25-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1-Pentanol, 5-chloro-, 4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Pentanol, 5-chloro-, 4-methylbenzenesulfonate(92948-25-9)
• EPA Substance Registry System: 1-Pentanol, 5-chloro-, 4-methylbenzenesulfonate(92948-25-9)

Safety Data

• Hazardous Substances Data: 92948-25-9(Hazardous Substances Data)

Usage

Molecular Structure

1-Pentanol molecule with a chlorine atom attached to the fifth carbon and a 4-methylbenzenesulfonate group.

Usage

Commonly used as an intermediate in the synthesis of various organic compounds, such as pharmaceuticals, agrochemicals, and dyes.

Industrial Applications

Has the potential to act as a surfactant, emulsifier, or dispersant in various industrial applications.

Solvent

Can be used as a solvent in organic reactions.

Component

Used as a component in the formulation of various consumer products.

Importance

Is important in the field of organic chemistry and has a range of potential industrial and commercial applications.

Upstream product

• 5259-98-3 5-chloropentan-1-ol 
• 98-59-9 p-toluenesulfonyl chloride 
• 142-68-7 TETRAHYDROPYRANE 

Downstream Products

• 54512-75-3 1-bromo-5-chloropentane 
• 1160105-89-4 C₁₀H₂₂ 
• 1224161-11-8 (R)-7-methylnonyl chloride 
• 1253597-04-4 8-cyclohexyloctyl 4-methylbenzenesulfonate 

Relevant articles and documents

New efficient imidazolium aldoxime reactivators for nerve agent-inhibited acetylcholinesterase

Herein, we described a new class of uncharged non-pyridinium reactivators for nerve agent-inhibited acetylcholinesterase (AChE). Based on a dual site binding strategy, we conjugated the imidazolium aldoxime to different peripheral site ligands (PSLs) of A

3- and 4-biphenyloxyaminoalkanes and related compounds as anti-inflammatory and analgetic agents

Compounds useful for treating inflammation, swelling and associated pain, represented by the formula: STR1 and the pharmaceutically acceptable acid addition salts thereof, wherein: a is an integer of 0-3; b is an integer of 0-2; n is an integer of 3-12; each X and each Y are independently -halo, --R1, -alkoxy, or -phenyl; and B is selected from the group consisting of: --NR1 R2, --NR1 (CH2 CH2 OH), STR2 in which R1 and R2 are independently H, alkyl or cycloalkyl; R3 is H, alkyl or --CH2 CH2 OH; and m is an integer of 3-8. Novel compounds are those wherein n is at least 6 if both a and b are 0.